| Integrin αvβ8-mediated TGF-β activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation JJ Worthington, A Kelly, C Smedley, D Bauché, S Campbell, JC Marie, ... Immunity 42 (5), 903-915, 2015 | 196 | 2015 |
| LAG3+ regulatory T cells restrain interleukin-23-producing CX3CR1+ gut-resident macrophages during group 3 innate lymphoid cell-driven colitis D Bauché, B Joyce-Shaikh, R Jain, J Grein, KS Ku, WM Blumenschein, ... Immunity 49 (2), 342-352. e5, 2018 | 154 | 2018 |
| Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions D Bauché, JC Marie Clinical & translational immunology 6 (4), e136, 2017 | 128 | 2017 |
| Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints N Gourdin, M Bossennec, C Rodriguez, S Vigano, C Machon, C Jandus, ... Cancer research 78 (13), 3604-3618, 2018 | 68 | 2018 |
| Diversity and expression of microRNAs in the filarial parasite, Brugia malayi CB Poole, W Gu, S Kumar, J Jin, PJ Davis, D Bauche, LA McReynolds PLoS One 9 (5), e96498, 2014 | 38 | 2014 |
| IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis D Bauché, B Joyce-Shaikh, J Fong, AV Villarino, KS Ku, R Jain, Y Lee, ... Science immunology 5 (46), eaav1080, 2020 | 36 | 2020 |
| SMAD4 TGF-β–independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation R Igalouzene, H Hernandez-Vargas, N Benech, A Guyennon, D Bauché, ... The Journal of clinical investigation 132 (8), 2022 | 20 | 2022 |
| MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype E Plantamura, A Dzutsev, M Chamaillard, S Djebali, L Moudombi, ... Proceedings of the National Academy of Sciences 115 (41), 10404-10409, 2018 | 20 | 2018 |
| Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions D Bauché, S Mauze, C Kochel, J Grein, A Sawant, Y Zybina, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 16 | 2020 |
| Induction and analysis of anti-CD40-induced colitis in mice B Joyce-Shaikh, DJ Cua, D Bauché Bio-protocol 9 (3), e3153-e3153, 2019 | 5 | 2019 |
| Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agents D LaFace, J Punnonen, E Bowman, D Bauche, A Chackerian, J Grein, ... US Patent App. 17/436,857, 2022 | 1 | 2022 |
| Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond JA Healy, JH Han, D Bauché, TE Keenan, J Casasnovas-Nieves, ... Annual Review of Cancer Biology 8, 2023 | | 2023 |
| SMAD4 TGF-SS-independent function dictates naive CD8+ T cell fate and prevents gut inflammation R Igalouzene, H Hernandez-Vargas, A Guyennon, N Benech, D Bauche, ... EUROPEAN JOURNAL OF IMMUNOLOGY 53, 105-105, 2023 | | 2023 |
| SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer via regulation of IFN-γ/STAT1 axis TG Tan, Y Zybina, C McKenna, A Olow, SJ Rukmini, MT Wong, ... Frontiers in Oncology 12, 1016307, 2022 | | 2022 |
| Polythérapies anticancéreuses comprenant des agents de blocage de ctla-4 et pd-1 L Annamalai, D Bauche, E Bowman, A Chackerian, J Grein, D Laface, ... | | 2022 |
| SMAD4 governs a feedforward regulation of the TGF-β-effects in CD8 T cells that contributes to preventing chronic intestinal inflammation R Igalouzene, H Hernandez-Vargas, N Benech, D Bauché, C Barrachina, ... bioRxiv, 2021.02. 19.431987, 2021 | | 2021 |
| Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agents D Laface, J Punnonen, E Bowman, D BAUCHE, A Chackerian, J Grein, ... | | 2020 |
| TGF-beta signaling in ILC3 prevents spontaneous microbiota-induced colorectal cancer D Bauche, K Lelu, J Noiret, C Ferreira, C Deceneux, P Guibert, I Treilleux, ... EUROPEAN JOURNAL OF IMMUNOLOGY 46, 277-277, 2016 | | 2016 |
| Rôle du TGF-bêta sur les ILC3 et les lymphocytes T dans le développement spontané de cancers colorectaux induits par le microbiote D Bauché Lyon 1, 2015 | | 2015 |
| Integrin αvβ8-mediated TGFβ activation by effector regulatory T cells is essential for suppression of T cell-mediated inflammation (CAM1P. 150) M Travis, A Kelly, C Smedley, D Bauché, S Campbell, J Marie, ... The Journal of Immunology 194 (1_Supplement), 48.7-48.7, 2015 | | 2015 |
